casci.blogg.se

She received the GSK Cardiovascular Foundation Young Investigator Award for this work. Her research focused on the effects of diet on endothelial stem cells and on novel biomarkers to identify these stem cells in vivo. Dr Foo previously was an Assistant Physician in Medicine, Division of Cardiology at Massachusetts General Hospital in Boston, where she served as an attending physician in heart failure/transplantation. Through her experience in both industry and practice, Dr Foo has developed deep expertise in both acute and chronic heart failure. She has served as clinical and translational medicine reviewer for numerous studies spanning the full spectrum of Phase I to Phase III clinical trials. She joins Cardioxyl from Novartis, where she was responsible for the establishment and execution of multiple novel programs in heart failure and the cardiorenal space, and is a named inventor on several associated patents applications. The Chief Medical Officer Summit will be held at the Colonnade Hotel on May 11-12, 2016 in Boston, MA.ĭr Foo was appointed Chief Medical Officer in 2013. Drs Foo and Wheeler will provide valuable insight and leadership during the course of the Summit, as we tackle the unique challenges faced by CMOs of emerging biotechs. ShiYin Foo, MD, PhD, CMO, Cardioxyl and Catherine Wheeler, MD, CMO, SVP Clinical Development, Acetylon Pharmaceuticals are confirmed to co-chair the event on May 11-12 th in Boston, MA. We are delighted to announce women leadership at the 4 th Annual Chief Medical Officer Summit. The Chief Medical Officer Summit 2016 Announces 2 New Co-Chairs